Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial 28 September 2018 by Audrey Thomson Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial
Appendix 4G and Corporate Governance Statement 29 August 2018 by Audrey Thomson Appendix 4G and Corporate Governance Statement 2018
Year End Accounts and Preliminary Final Report 29 August 2018 by Audrey Thomson Year End Accounts and Preliminary Final Report
Appendix 3B – New Issue Announcement 14 June 2018 by Audrey Thomson Appendix 3B – New Issue Announcement
Appendix 3B – New Issue Announcement 28 May 2018 by Audrey Thomson Appendix 3B – New Issue Announcement
Appendix 3B – New Issue Announcement 16 May 2018 by Audrey Thomson Appendix 3B – New Issue Announcement